This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, medical image sharing could also produce an influx of questions from patients who have concerns about what they're looking at, authors of a new paper suggest.
AuntMinnie.com spoke with Casey Chollet-Lipscomb, MD, who joined radiation oncologists from around the U.S. in Washington, D.C., on May 20 and 21 to lobby for a recently introduced bill that proposes a new payment model for radiation therapy. The Radiation Oncology Case Rate Value-Based Payment Program Act, or ROCR Act, was introduced in Congress last week and aims to improve the way Medicare pays for radiation therapy -- a highly effective treatment for a large portion of cancer patients, Choll
Experts have identified numerous white matter features, in addition to changes in white matter tracts that occur over time, which they believe are more common among people with ADHD.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Consideration is needed for breast cancer screening in women younger than 40 years, according to research presented at the American Roentgen Ray Society (ARRS) annual meeting. Manisha Bahl, MD, from Massachusetts General Hospital in Boston presented the findings, which showed that women between the ages of 30 and 39 years have a cancer detection rate of nearly three per 1,000, with about half of screening-detected cancers being invasive.
ACR, the Society of Interventional Radiology and others believe these restrictions will force patients to consider problematic alternatives for their back pain, such as opioids.
ACR, the Society of Interventional Radiology and others believe these restrictions will force patients to consider problematic alternatives for their back pain, such as opioids.
Although studies have shown AI to be effective as a support tool, several have also highlighted issues related to the potential for bias in algorithms that have not been trained on diverse datasets.
Patient characteristics influenced false-positive results on digital breast tomosynthesis (DBT) when analyzed by an AI algorithm approved by the U.S. Food and Drug Administration (FDA), a study published May 21 in Radiology found. Researchers led by Derek Nguyen from Duke University in Durham, NC found that false-positive case scores as assigned by the algorithm were significantly more likely in Black and older patients and less likely in Asian patients and younger patients compared to white p
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
South Korean AI software developer Lunit has completed a $193 million acquisition of breast and lung imaging software firm Volpara Health Technologies. The deal, announced late last year , is expected to boost Lunit’s capabilities in AI-driven cancer diagnostics and brings the company access to Volpara’s installed base in the U.S. market. In addition, Lunit will integrate Volpara’s breast density and screening workflow platform with its AI-powered solutions for breast cancer detection.
GE HealthCare topped a list of AI-enabled medical devices to receive 510(k) clearance by the U.S. Food and Drug Administration (FDA) this year, at 72. The company noted that the cleared devices include some from recently acquired companies BK Medical, Caption Health, and MIM Software, such as the following: Precision DL – deep learning-based image processing software engineered to provide increased small, low-contrast lesion detectability compared to the company’s conventional Time-of-Flight PET
“Medicare Advantage undermines my expertise as a physician and disregards my patients’ unique medical needs," said radiation oncologist Todd E. Hlavaty, MD.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Delphinus Medical Technologies has appointed Rama Gundlapalli as its vice president of engineering. Gundlapalli has more than 30 years of experience in product development and engineering, having worked in startup, small, and Fortune 500 companies and applied knowledge in research and development to building successful commercial product pipelines. He was previously senior director of research collaborations at Siemens Healthineers.
christine.book Tue, 05/21/2024 - 10:36 May 21, 2024 — According to a newly-published study of nearly 5,000 screening mammograms interpreted by an FDA-approved AI algorithm, patient characteristics such as race and age influenced false positive results. The study’s results, “Patient Characteristics Impact Performance of AI Algorithm in Interpreting Negative Screening Digital Breast Tomosynthesis Studies” were published today in Radiology , a journal of the Radiological Society of North America (
Researchers also noted that mammography-based AI software was associated with over a threefold higher likelihood of false-positive risk scores in patients 61 to 70 years of age in comparison to women 51 to 60 years of age.
Noninvasive brain scans for children under the age of 1 could identify risk factors and reduce the potential for stroke later in life, say researchers at the University of South Australia.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Researchers from the University of Liverpool and Queen Mary University of London have published the first study in the UK to demonstrate the benefits of lung cancer screening across socioeconomic groups. Evidence in the new study illustrates the value and importance of screening, especially for those who live in areas of economic deprivation.
How did Cedars-Sinai carve their path to clinical AI adoption across service lines? In this webinar clip, Jonathan Steinberger, MD, Vascular and Interventional Radiologist at Cedars-Sinai Medical Center Imaging group, explains the renowned facility’s timeline of AI adoption and working with Aidoc, growing from limited use cases (ICH, PE, C-Spine FX) to an enterprise wide system and EPIC integration.
milla1cf Tue, 05/21/2024 - 07:00 May 21, 2024 — IBA , a world leader in particle accelerator technology, announced that it has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health , Hartford HealthCare and Proton International , for the installation of a Proteus ONE compact proton therapy system.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Trending Topics in the World of Work Our May issue of SHIFT stresses the importance of aligning employment with health drivers; using human-work models to boost employee performance; how “quiet quitting” has evolved into “resenteeism”; and how “shift shock” is sweeping social media. Working to Thrive Better aligning employment with modifiable drivers of health could unlock years of higher-quality life and create trillions of dollars of economic value, accordin
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0. This is the result of joint testing activities between RaySearch and Varian Medical Systems during 2024. In May 2023, RayCare 5B was certified to be interoperable with TrueBeam 3.0.
In a market that’s constantly evolving, recruiting with a “set menu” approach doesn’t work. Instead of doing the same thing over and over, we have to constantly create new solutions for clients and candidates. What if you could treat recruiting like an adventure? What if you went into the market every single year with a new recruiting product, tailored to the exact demands of your dig at that time?
How did Cedars-Sinai carve their path to clinical AI adoption across service lines? In this webinar clip, Jonathan Steinberger, MD, Vascular and Interventional Radiologist at Cedars-Sinai Medical Center Imaging group, explains the renowned facility’s timeline of AI adoption and working with Aidoc, growing from limited use cases (ICH, PE, C-Spine FX) to an enterprise wide system and EPIC integration.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content